Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRA-TB Project
RBR-49dt8yjPhase 4Not yet recruiting
- Sponsor
- Escola de Enfermagem de Ribeirão Preto
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rifapentine + isoniazid in pulmonary tuberculosis (TB), latent tuberculosis infection (LTBI) and Tuberculosis (TB) (3 arms), sponsored by Escola de Enfermagem de Ribeirão Preto. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
rifapentine + isoniazid
03
Conditions
pulmonary tuberculosis (TB)latent tuberculosis infection (LTBI)Tuberculosis (TB)
Beyond the preview
Go deeper on RBR-49dt8yj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-49dt8yj.